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The CRISPR-Cas9 system is frequently used to create
small deletions in the genomes of mammalian cells,
but the isolation of precisely targeted mutants is still
challenging. A new, two-step ‘pop in & out’ targeting
approach facilitates this task.enrichment of targeted cells are increasingly demandedGene editing in mammalian cells using
CRISPR-Cas9
Genetic engineering in mammalian cells is flourishing in
recent years thanks to the use of sequence-specific nu-
cleases that create double-strand breaks (DSBs) in genes
of interest, enforcing the repair of the disrupted se-
quences. Proof-of-principle was provided by methodolo-
gies involving zinc-finger nucleases and TALENs, both
of which have been superseded by the more versatile
CRISPR-Cas9 gene-editing system [1]. This system is
composed of the nuclease Cas9, which is guided to spe-
cific DNA sequences by short complementary single
guide RNAs (sgRNAs) to create targeted DSBs. Gene
editing at DSBs is mediated by cellular DNA repair
mechanisms, either the imprecise non-homologous end
joining (NHEJ) pathway (mutNHEJ), which leads to
small deletions, or homology-directed repair (HDR),
which utilizes an homologous DNA molecule as a repair
template, leading to precise nucleotide insertions or re-
placements. In cell lines such as HEK293, CRISPR-Cas9
can be used efficiently to generate knockout alleles that
result from small, frame-shifting deletions; these dele-
tions reach high frequencies upon transfection with
Cas9 and sgRNA expression vectors [2]. By contrast,
HDR repair [3], being restricted to the S and G2 phases
of the cell cycle, requires an additional co-transfected
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modified by HDR are obtained at substantially lower fre-
quencies. In specific experimental settings, the recovery
of targeted clones may be further complicated by the
resistance of cell lines to transfection procedures, in-
accessibility of the target locus or a limited efficacy of
individual sgRNAs. Thus, methods and protocols for the
to avoid the expansion and screening of large numbers
of clones. The recent work of Thomas Cech and col-
leagues published in Genome Biology [4] provides a new
and smart solution that can accomplish this task.Enrichment and isolation of mutant cells
Three ways to enrich targeted cells within or from Cas9-
transfected populations have been described to date. In
the first approach, cells are transfected with an add-
itional fluorescent reporter gene or a nuclease reporter
construct, allowing the fluorescence-activated cell sort-
ing (FACS) enrichment of successfully transfected cells,
which are subsequently cloned and genotyped [5, 6].
Alternatively, the activity of NHEJ key molecules, such
as DNA ligase IV, can be suppressed in transfected cul-
tures, leading to a global increase of HDR events in the
cell population [7, 8]. The timed delivery approach uses
cultures synchronized for the S phase of the cell cycle
for transfection, in order to maximize the proportion of
cells that are able to undergo HDR repair [9]. Neverthe-
less, none of these methods allows the direct selection of
cells that harbor the desired targeted allele, unless the
HDR template vectors also include selection markers
such as drug resistance or reporter genes. The use of
drug-selectable gene-targeting vectors is well established
and mandatory for gene targeting in mouse embryonic
stem (ES) cells [10] because the frequency of spontan-
eously occurring HDR, without assistance by site-
specific nucleases, is very low. The approach described
by Cech and colleagues [4] uses the classic targeting-cle is distributed under the terms of the Creative Commons Attribution 4.0
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geted clones induced by CRISPR-Cas9 gene editing. Cech
and colleagues were troubled by the low frequencies of
CRISPR-Cas9-induced HDR in the telomerase reverse
transcriptase gene (TERT) in HEK293 and other cell lines.
To overcome this problem, Cech and colleagues designed
a two-step ‘pop in & out’ targeting strategy using vectors
that contained a fluorescent marker gene and FACS for
the isolation of targeted clones, followed by the removal of
the selection marker in the second step.
A simple ‘pop in & out’ targeting approach for
use with CRISPR-Cas9
In the first application of the pop in & out approach
(Fig. 1a), Cech and colleagues set out to add an N-terminal
tag to the TERT protein to enable its visualization. The tar-
geting vector included TERT homology regions and the
tag-coding segment, interrupted with a loxP-flanked green
fluorescent protein (GFP) gene that allowed the isolation
of cells harboring either random or recombined stable gen-
omic vector integrations. Random vector integrations usu-
ally occur in only approximately 1 in 10,000 transfected
cells; consequently, this background could be outcompeted
by the stimulatory effect on HDR of co-transfected Cas9
and a TERT-specific sgRNA, which occurs in a larger frac-
tion of cells. Indeed, Cech and colleagues found that 84 %
of the clones established from the FACS-enriched GFP+
population contained targeted TERT alleles. In the second
step of the in & out procedure, the loxP-flanked GFP
marker could be excised from the targeted locus byA
Fig. 1 Two step, ‘pop in & out’ approach for the generation of CRISPR-Cas9
(homology regions shaded gray) introduces a tag segment that is disrupte
Cas9 and sgRNA-induced double strand break (DSB) stimulates homology-d
by fluorescence-activated cell sorting (FACS). In the ‘out’ step, the marker
subsequently enriched by FACS. b Two step in & out targeting approach
targeting vector introduces a nucleotide replacement (a single nucleotid
from the targeted allele using Cas9 and a pair of sgRNAs that recognize
with a targeting vector to provide sequences (homology regions shaded) tha
enriched by FACStransient expression of Cre recombinase and the enrich-
ment by FACS of GFP-negative cells (Fig. 1a). All of the
clones established from the GFP− fraction had lost the
marker gene, resulting in tagged alleles that could be used
to study TERT localization. A single loxP site of 34 bp
remained within the targeted allele, which could be toler-
ated as an additional segment within the tag-coding region.
In studies in which the insertion of a loxP sequence within
a coding region needs to be avoided, vector design could
be easily modified by placing the GFP marker into a neigh-
boring intron region.
In the second application of the pop in & out approach
(Fig. 1b), Cech and colleagues aimed to introduce a single
base-pair replacement into the TERT promoter region, in
order to test for the functionality of a single nucleotide
polymorphism (SNP), without leaving any unrelated se-
quence trace in the genome. The vector for the first, ‘in’
targeting step included a GFP marker gene next to the de-
sired nucleotide replacement. Targeted ‘in’ clones were
established from the GFP+ cell population isolated by
FACS. In the second, ‘out’ step, the marker could be com-
pletely removed upon transfection with Cas9 and a pair of
sgRNAs that cut at both ends of the GFP gene, followed
by HDR with a marker-free targeting vector containing
only the SNP mutation (Fig. 1b). GFP-free clones were
isolated by Cech and colleagues from GFP− cells enriched
by FACS, but a background of silenced, GFP− cells made
the identification of targeted clones less efficient. Never-
theless, the ‘out’ step, which enables the seamless excision
of the GFP gene from the targeted locus while preservingB
-induced targeted mutants. a In the ‘in’ step, the targeting vector
d by a loxP-flanked green fluorescent protein (GFP) reporter gene. A
irected repair (HDR) and enables the enrichment of targeted GFP+ cells
is deleted by Cre/lox-mediated recombination and GFP− cells are
for the seamless removal of a marker gene. In the first step, the
e polymorphism (SNP)) next to a GFP reporter. The marker is removed
the end of the marker cassette. The marker gene is removed by HDR
t are wild type except for the SNP, and GFP− cells are subsequently
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marker removal by Cre recombinase leaving a loxP site in
the genome.
The work of Cech and colleagues capitalizes on the flexi-
bility of targeting vector design, which is well established
in the field of mouse ES cells, and combines it with
CRISPR-Cas9 gene editing. While most applications of
CRISPR-Cas9 aim to introduce desired mutations in a
single targeting step, low recombination efficiencies
may necessitate major efforts to reach this goal. In
these cases, the two-step in & out procedure is a more
rational way to obtain targeted mutants, although it re-
quires a second cycle of vector construction and clone
isolation. Thus, the in & out targeting approach adds to
the versatility of CRISPR-Cas9-mediated genome engin-
eering and offers a new method for the direct selection
of cells harboring targeted mutations. In future, it may
be further combined with the suppression of NHEJ repair
or the timed delivery approach, simplifying targeted muta-
genesis for the benefit of genetic research.Conclusions
Genome engineering using the CRISPR-Cas9 system is
becoming increasingly popular and its applications are
continuously expanding. The two-step gene-targeting
strategy developed by Cech and colleagues is a new de-
velopment that facilitates the generation of precisely
modified knock-in alleles in mammalian cells.
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